Neuland Laboratories Ltd

{"amount":12}

{"actualRevenue":4397093000,"estimateRevenue":4507000000,"revenueSurprise":-109907000,"revenueSurprisePercent":-2.438584424228977,"actualEPS":31.62,"estimateEPS":57.6504,"surprise":-26.0304,"surprisePercent":-45.15215852795471}

{"actualRevenue":7762503000,"estimateRevenue":5590000000,"revenueSurprise":2172503000,"revenueSurprisePercent":38.86409660107334,"actualEPS":165.76,"estimateEPS":79.72319999999999,"surprise":86.0368,"surprisePercent":107.9194011279025}

{"actualRevenue":2927527000,"estimateRevenue":3679000000,"revenueSurprise":-751473000,"revenueSurprisePercent":-20.42601250339766,"actualEPS":10.83,"estimateEPS":52.5606,"surprise":-41.7306,"surprisePercent":-79.39521238342029}

{"actualRevenue":5142731000,"estimateRevenue":4441000000,"revenueSurprise":701731000,"revenueSurprisePercent":15.8011934249043,"actualEPS":75.49,"estimateEPS":56.0184,"surprise":19.4716,"surprisePercent":34.75929337503391}

{"description":"Neuland Laboratories said Q4 FY26 total income jumped 134.9% YoY, driven by commercial CMS projects, with stronger margins and earnings discussed in the results call.","url":"https://finance.yahoo.com/sectors/healthcare/articles/neuland-laboratories-ltd-bom-524558-010115987.html","sentiment":"Positive","domain":"Yahoo Finance"}

{"description":"Neuland Laboratories' Q4 FY26 earnings call reported record revenue of INR 788.7 crore, up 134.9% YoY, driven by commercial CMS projects and favorable currency movement; FY26 revenue rose 37%.","url":"https://finance.yahoo.com/quote/NEULANDLAB.BO/earnings/NEULANDLAB.BO-Q4-2026-earnings_call-554015.html","sentiment":"Positive","domain":"Yahoo Finance"}

{"description":"Neuland Laboratories rose nearly 8% on May 13 after Q4 profit jumped 665% to ₹212.7 crore, revenue doubled to ₹776.25 crore and EBITDA surged 502%; management warned the quarter was lumpy.","url":"https://www.cnbctv18.com/market/neuland-laboratories-share-price-q4-result-reaction-pipeline-launches-margins-outlook-ws-l-19904402.htm","sentiment":"Positive","domain":"CNBCTV18"}

{"description":"Neuland Laboratories' Q4 net profit jumped over 7x to ₹213 crore on strong US and Europe export orders; FY26 revenue rose 37%. Board also approved a ₹34 final dividend and a 120.5 KL capacity expansion.","url":"https://www.cnbctv18.com/market/earnings/neuland-labs-q4-result-profit-surges-7x-to-rs-213-crore-as-export-orders-drive-strong-quarter-ws-l-19904042.htm","sentiment":"Positive","domain":"CNBCTV18"}

{"description":"Neuland Laboratories reported a net profit of ₹129 crore for Q2 FY26, a 166% increase from last year. Revenue rose 63.7% to ₹516 crore, with EBITDA improving to ₹156.9 crore. The company expects continued growth momentum, reflecting strong CMS project performance.","url":"https://www.cnbctv18.com/market/stocks/neuland-laboratories-share-price-q2-results-net-profit-jumps-over-2-fold-on-strong-cms-project-revenue-19749206.htm","sentiment":"Positive","domain":"CNBCTV18"}